Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

AI-Powered Chatbot Integrated With Wearable-Derived Data for Promoting Mental Health Among Finnish Higher Education Students

10 de noviembre de 2026 actualizado por: Anna Axelin, University of Turku

Mental health problems among adolescents and young adults have increased globally, underscoring the urgent need for accessible, preventive, and systemic approaches to promoting student mental health. This pilot study aims to evaluate the feasibility, conversational quality, and preliminary effectiveness of an AI-powered chatbot integrated with wearable-derived physiological data intervention to provide personalized and timely mental health support for Finnish higher education students. The study explores how real-time stress indicators, such as heart rate variability (HRV), can inform the chatbot's adaptive and proactive interactions to promote students' mental health in daily life.

The study setting will be the Faculty of Medicine, University of Turku in Finland. A total of 15-20 participants will be recruited with convenience sampling for this study. The inclusion criteria for participants are: 1) enrolled students at the Faculty of Medicine, 2) voluntary and consenting, 3) Finnish-speaking, 4) having a smart phone (Android/iOS), and 5) having none to mild levels of psychological distress. Participants who self-report a diagnosis of mental health disorder, or having an acute treatment for mental health will be excluded.

The intervention in this study consists of 4-week daily use of a AI-powered chatbot. In addition to access to the chatbot, a wearable device will be given to each participant to collect physiological data related to their stress (HRV), physical activity and sleep. At the end of week 2 and 3 of the study, participants will receive a personalized report summarizing the data collected by the device. Throughout the intervention period, the research assistant will contact participants once a week to ensure their well-being. At the end of the study, an interview will be arranged with each participant.

The study data includes the conversations with the chatbot, physiological data from the wearable device, daily stress questions, background information questionnaire, Depression Anxiety Stress Scale (DASS-21) (at the beginning of the intervention and at weeks 2 and 4), Chatbot Usability Questionnaire (CUQ) (at weeks 2 and 4) and an end-of-study semi-structured interview.

Descripción general del estudio

Estado

Reclutamiento

Condiciones

Tipo de estudio

De observación

Inscripción (Estimado)

20

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

  • Nombre: Anna Axelin
  • Número de teléfono: +358405029905
  • Correo electrónico: anmaax@utu.fi

Ubicaciones de estudio

      • Turku, Finlandia
        • Reclutamiento
        • University of Turku
        • Contacto:
          • Anna Axelin
          • Número de teléfono: +358405029905
          • Correo electrónico: anmaax@utu.fi

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Niño
  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

Sí

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Study population consists of higher education students.

Descripción

Inclusion Criteria:

  • enrolled students at the Faculty of Medicine (bachelor's, master's, or doctoral level students)
  • voluntary and consenting
  • Finnish-speaking (native speaker or enrolled in a Finnish study program)
  • having a smart phone (Android/iOS)
  • having none to mild levels of psychological distress

Exclusion Criteria:

  • self-reported diagnosis of mental health disorder, or having an acute treatment for mental health

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: PROSPECTIVE

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
Higher education students

Daily use of an AI-powered chatbot and a wearable device to collect physiological data related to stress, physical activity and sleep.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Eligibility of participants
Periodo de tiempo: 4 weeks

The number of individuals screened, the proportion that meets the inclusion criteria, and the main reasons for exclusion will be documented to assess the appropriateness and practicality of the eligibility criteria.

4 weeks
Recruitment and retention of participants
Periodo de tiempo: 4 weeks

The number of participants enrolled, the proportion completing the whole intervention as well as assessments, and attrition rates will be recorded to evaluate recruitment efficiency and participant retention.

4 weeks
Engagement of the participants
Periodo de tiempo: 4 weeks

Quantitative indicators that include the frequency of chatbot interactions, average session length, and response rates will be analyzed to assess adherence to study procedures and sustained engagement over time.

4 weeks
Technical performance of the chatbot
Periodo de tiempo: 4 weeks

System reliability will be examined through logs of technical errors, data integration issues, and chatbot downtime events, providing insights into the stability and operational consistency of the intervention platform.

4 weeks
Safety of the chatbot
Periodo de tiempo: 4 weeks

It will be assessed whether the chatbot's interactions are free from harm and whether it can appropriately identify and manage high-risk user input.

Evaluation focuses on the chatbot's ability to detect and respond to indications of severe distress or crisis, such as expressions of self-harm, suicidal ideation, abuse, or other high-risk situations.

Following the MHealth-EVAL framework (Chen et al., 2024), responses will be annotated using a binary scale, where "0" indicates the presence of harmful or unsafe content or failure to address crisis cues appropriately, and "1" indicates a safe and supportive response.

4 weeks

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Psychological distress
Periodo de tiempo: 4 weeks

Psychological distress will be assessed using the Depression Anxiety Stress Scales-21 (DASS-21), which is a 21-item self-report instrument measuring three dimensions of negative emotional states: depression, anxiety, and general stress. Each subscale includes seven items rated on a 4-point Likert scale (0-3), with higher scores indicating greater symptom severity. DASS-21 will be administered before, at two weeks, and after the intervention to assess potential changes in participants' psychological stress.

4 weeks
Behavioral change and health literacy
Periodo de tiempo: 4 weeks

At the end of the 4-week intervention, semi-structured interviews will be conducted with each participant individually to gain an in-depth understanding of their experiences with the chatbot as well as any behavioral changes they perceived during the study. In addition, the participants' understanding of AI health literacy will be discussed.

4 weeks

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

7 de septiembre de 2026

Finalización primaria (Estimado)

1 de diciembre de 2026

Finalización del estudio (Estimado)

1 de diciembre de 2026

Fechas de registro del estudio

Enviado por primera vez

25 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Publicado por primera vez (Actual)

17 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

17 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

10 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • TY/2154/2025

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

SÍ

Descripción del plan IPD

Dataset may be made available for secondary use through the international open science repository Dryad. Identifiers will be removed from the dataset to ensure that individual participants cannot be identified. Secondary use of the data requires a permission process that adheres to established research ethics principles.

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir